Literature DB >> 16997854

Mycobacteria-primed macrophages and dendritic cells induce an up-regulation of complement C5a anaphylatoxin receptor (CD88) in CD3+ murine T cells.

Mary Anne Connelly1, Rachel A Moulton, Amanda K Smith, Devin R Lindsey, Meenal Sinha, Rick A Wetsel, Chinnaswamy Jagannath.   

Abstract

Complement C5a anaphylatoxin is a potent activator of macrophages, neutrophils, and dendritic cells (DC) and binds the C5a receptor (C5a-R; CD88). Although C5a is chemotactic for T cells, expression of C5a-R on murine T cells has been disputed. We report here that naïve, Con A-activated, and cytokine (IL-12, IL-18)-stimulated murine CD3+ T cells from three strains of mice [C57Bl/6, B10.nSn (C5+/+), B10.on (C5-/-)] lacked C5a-R, as evaluated by immunophenotyping with an anti-C5a-R mAb. Ligation of CD3 induced a modest up-regulation with 3% of CD3+ T cells expressing cell surface C5a-R. T cells primed by APC differentiate into effector T cells. Activation of mycobacteria [bacillus Calmette-Guerin (BCG)]-sensitized T cells through MHC II and TCR interactions via BCG-infected macrophages enhanced the expression of C5a-R with approximately 14% of CD3+ T cells positive for C5a-R. Comparable expression was found in C5+/+ as well as C5-/- strains of mice (14% and 15%, respectively). Furthermore, anti-CD3-activated T cells were primed by BCG-infected DC, and a larger proportion of the primed T cells expressed C5a-R (30-40%). Finally, mice infected with BCG showed significant numbers of CD3+ T cells expressing C5a-R in the spleens during infection. As APC, such as macrophages and DC, can secrete C5 and cleave C5 to C5a and C5b through a peptidase, we suggest that macrophage and DC-T cell interactions can up-regulate C5a-R on T cells through MHC II-TCR and provide a C5a peptide for additional local activation of T cells via C5a-R.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997854     DOI: 10.1189/jlb.1005582

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

Review 1.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

2.  Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection.

Authors:  Vasile Pavlov; Hugo Raedler; Shuguang Yuan; Staci Leisman; Wing-Hong Kwan; Peter N Lalli; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.

Authors:  Cherie M Roche; Amanda Smith; Devin R Lindsey; Akshay Meher; Kimberly Schluns; Ashish Arora; Lisa Y Armitige; Chinnaswamy Jagannath
Journal:  Tuberculosis (Edinb)       Date:  2011-11-13       Impact factor: 3.131

4.  Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Biochimie       Date:  2008-04-27       Impact factor: 4.079

5.  The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells.

Authors:  Muralidhar K Katti; Guixiang Dai; Lisa Y Armitige; Carlos Rivera Marrero; Sundarsingh Daniel; Christopher R Singh; Devin R Lindsey; Subramanian Dhandayuthapani; Robert L Hunter; Chinnaswamy Jagannath
Journal:  Cell Microbiol       Date:  2008-01-31       Impact factor: 3.715

6.  Complement 5a receptor inhibition improves renal allograft survival.

Authors:  Faikah Gueler; Song Rong; Wilfried Gwinner; Michael Mengel; Verena Bröcker; Sylvia Schön; Tim Friedrich Greten; Heiko Hawlisch; Thomas Polakowski; Karsten Schnatbaum; Jan Menne; Hermann Haller; Nelli Shushakova
Journal:  J Am Soc Nephrol       Date:  2008-08-27       Impact factor: 10.121

Review 7.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

Review 8.  Complement anaphylatoxins as immune regulators in cancer.

Authors:  Eli T Sayegh; Orin Bloch; Andrew T Parsa
Journal:  Cancer Med       Date:  2014-04-08       Impact factor: 4.452

9.  IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.

Authors:  Hilde L Orrem; Per H Nilsson; Søren E Pischke; Ola Kleveland; Arne Yndestad; Karin Ekholt; Jan K Damås; Terje Espevik; Bjørn Bendz; Bente Halvorsen; Ida Gregersen; Rune Wiseth; Geir Ø Andersen; Thor Ueland; Lars Gullestad; Pål Aukrust; Andreas Barratt-Due; Tom E Mollnes
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.